mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Mammalian target of rapamycin (mTOR) is a key protein kinase regulating skeletal muscle protein metabolism.
• mTOR integrates signals from nutrients, growth factors, and cellular cues to control muscle protein synthesis and degradation.
• mTOR influences muscle protein balance by regulating translation and inhibiting proteasomal and autophagic degradation pathways.

Purpose of the Study:

• To review the normal signaling pathways of mTOR in skeletal muscle.
• To examine the aberrant regulation of mTOR signaling in the context of sepsis and inflammation.
• To elucidate the mechanisms by which sepsis-induced muscle atrophy occurs via mTOR dysregulation.

Main Methods:

• Literature review of mTOR signaling in skeletal muscle.
• Analysis of studies investigating sepsis and inflammation models.
• Examination of molecular mechanisms underlying mTOR pathway alterations.

Main Results:

• Normal mTOR signaling promotes muscle protein synthesis and inhibits degradation.
• Sepsis disrupts mTOR signaling, leading to impaired protein synthesis and increased degradation.
• Aberrant mTOR regulation contributes significantly to sepsis-induced muscle atrophy.

Conclusions:

• Understanding mTOR's role in sepsis-induced muscle atrophy is crucial for developing therapeutic strategies.
• Targeting mTOR signaling pathways may offer potential treatments for muscle wasting conditions associated with sepsis.
• Further research is needed to fully elucidate the complex interplay between mTOR, sepsis, and muscle metabolism.